Skip to main content

Advertisement

Table 1 Characteristics of study participants who did or did not have HIV-related ocular disease (n = 149, unless otherwise specified)

From: Prevalence of HIV-associated ophthalmic disease among patients enrolling for antiretroviral treatment in India: A cross-sectional study

Characteristic Participants with HIV-related ocular conditions (%) (n = 26) Participants without HIV related eye conditions (%) (n = 123) P-value
Median age (n = 148)    
   Years 38 36 0.95
Gender    
   Male [n(%)] 18 (69.2) 86 (69.9) 0.94
Marital status    
   Single 3 (11.5) 13 (10.6) 0.81
   Married 20 (76.9) 88 (70.7)  
   Divorced 0 2 (1.6)  
   Widowed 3 (11.6) 21 (17.1)  
Occupation    
   None 13 (50.0) 55 (44.7) 0.44
   Unskilled 2 (7.7) 22 (17.9)  
   Skilled 11(42.3) 46 (37.4)  
Exposure (n = 147)    
   Heterosexual 26 (100.0) 113 (93.4) 0.99
   Homosexual 0 4 (3.3)  
   Blood transfusion 0 2 (1.7)  
   Intravenous drug use 0 2 (1.7)  
Median CD4 count    
   Cells/μL 106 200 0.003
CD4 count (cells/μL)    
   0-50 7 (26.9) 6 (4.9) 0.003
   51-100 6 (23.1) 17 (13.8)  
   101-150 5 (19.2) 18 (14.6)  
   151-200 2 (7.7) 23 (18.7)  
   201-250 2 (7.7) 25 (20.3)  
   >250 4 (15.4) 34 (27.6)  
WHO clinical stage    
   1/2 2 (7.8) 58(47.2) <0.001
   3/4 24 (92.3) 65 (52.8)  
Months since HIV diagnosis    
   ≤ 12 11 (42.3) 51 (42.5) 0.94
   13-24 6 (23.1) 27 (22.5)  
   25-60 5 (19.2) 28 (23.3)  
   >61 4 (15.4) 14 (11.7)  
Tuberculosis status    
   No history 7 (26.9) 63 (51.2) 0.07
   Past history 11 (42.3) 31 (25.2)  
   Current 8 (30.8) 29 (23.6)  
History of eye symptoms (n = 148)    
   None 24 (92.3) 113 (92.6) 0.82
   Reduced vision 2 (7.7) 6 (4.9)  
   Pain 0 2 (1.6)  
   Floaters 0 1 (0.8)  
Visual acuity (n = 142)    
   None 20 (80.0) 110 (94.0) 0.02
   Visual impairment 4 (16.0) 7 (5.6)  
   Blind 1 (4.0) 0